Postoperative genetic testing confirmed the IDH1 R132H mutation, 1p/19q co-deletion, and pTERT mutation, resulting in a final diagnosis of oligodendroglioma, WHO CNS grade 2. The gene discussed is IDH1; the disease is oligodendroglioma.